A detailed history of Chris Bulman Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Chris Bulman Inc holds 2,464 shares of ABBV stock, worth $423,142. This represents 0.33% of its overall portfolio holdings.

Number of Shares
2,464
Previous 2,449 0.61%
Holding current value
$423,142
Previous $420 Million 15.88%
% of portfolio
0.33%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $2,457 - $2,989
15 Added 0.61%
2,464 $487 Million
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $379,080 - $442,681
2,449 New
2,449 $420 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Chris Bulman Inc Portfolio

Follow Chris Bulman Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chris Bulman Inc, based on Form 13F filings with the SEC.

News

Stay updated on Chris Bulman Inc with notifications on news.